Literature DB >> 20380975

Risk factors and medical management of vasospasm after subarachnoid hemorrhage.

Christos Lazaridis1, Neeraj Naval.   

Abstract

Vasospasm is a major cause of morbidity and mortality following aneurysmal subarachnoid hemorrhage. This article reviews the risk factors for vasospasm; the various methods for diagnosing vasospasm including the conventional 4-vessel angiography, computed tomographic angiography, and computed tomographic perfusion; the methods to detect vasospasm before clinical onset (including transcranial Doppler ultrasonography); and the recent emergence of multimodality monitoring. A discussion of medical treatment options in the setting of vasospasm is also included; the prophylactic use of "neuroprotectants" such as nimodipine, statins, and magnesium and the role of hemodynamic augmentation in vasospasm amelioration, including the use of inotropic support in addition to traditional triple-H therapy, are discussed. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20380975     DOI: 10.1016/j.nec.2009.10.006

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  8 in total

Review 1.  Advanced hemodynamic monitoring: principles and practice in neurocritical care.

Authors:  Christos Lazaridis
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

2.  High risk of new episode of symptomatic vasospasm in unaffected arteries in subarachnoid hemorrhage patients receiving targeted endovascular treatment for symptomatic focal vasospasm.

Authors:  Wondwossen G Tekle; Saqib A Chaudry; Ameer E Hassan; Habib Qaiser; Mikayel Grigoryan; Gustavo J Rodriguez; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

3.  Reliability of CT Angiography in Cerebral Vasospasm: A Systematic Review of the Literature and an Inter- and Intraobserver Study.

Authors:  L Letourneau-Guillon; B Farzin; T E Darsaut; M Kotowski; F Guilbert; M Chagnon; A Diouf; D Roy; A Weill; M Lemus; C Bard; M Belair; D Landry; L Nico; A Tellier; R Jabre; C Kauffmann; J Raymond
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-26       Impact factor: 3.825

4.  Innovative approach for prevention and treatment of post subarachnoid hemorrhage vasospasm: A preliminary report.

Authors:  Neelam K Venkataramana; Shailesh A V Rao; Arun L Naik; Kishore Shetty; Paparaja Murthy; Abhilash Bansal; Christos Panotopoulos
Journal:  Asian J Neurosurg       Date:  2012-04

5.  Continuous measurement of cerebral oxygenation with near-infrared spectroscopy after spontaneous subarachnoid hemorrhage.

Authors:  Homajoun Maslehaty; Ulf Krause-Titz; Athanassios K Petridis; Harald Barth; Hubertus Maximilian Mehdorn
Journal:  ISRN Neurol       Date:  2012-11-14

6.  The relationship between subarachnoid hemorrhage volume and development of cerebral vasospasm.

Authors:  Sang-Won Jung; Chang-Young Lee; Man-Bin Yim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2012-09-28

7.  High-sensitivity C-reactive protein as a predictive factor of acute kidney injury following aneurysmal subarachnoid hemorrhage: a prospective observational study.

Authors:  Bi-Hui Yang; Qiu He; Chen-Yu Ding; De-Zhi Kang; Qing-Xi Tang
Journal:  Acta Neurochir (Wien)       Date:  2019-07-17       Impact factor: 2.216

8.  Prophylactic intra-arterial injection of vasodilator for asymptomatic vasospasm converts the patient to symptomatic vasospasm due to severe microcirculatory imbalance.

Authors:  Norihito Shimamura; Masato Naraoka; Naoya Matsuda; Kiyohide Kakuta; Hiroki Ohkuma
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.